Glucotrack, Inc. (GCTK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Glucotrack, Inc., a Delaware corporation, on May 17, 2024. The report details the effective implementation of a corporate action approved by stockholders at the annual meeting on April 26, 2024.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on capital structure adjustments.
Material Changes
The primary material change is the execution of a one-for-five (1:5) reverse stock split of the Company's common stock, effective at 4:30 p.m. on May 17, 2024. Key adjustments include:
- Outstanding Shares: Reduced from 27,392,996 to approximately 5,478,599 shares.
- Authorized Shares: Reduced from 500,000,000 to 100,000,000 shares.
- Par Value: Remained unchanged at $0.001 per share.
- Derivatives: Stock options and warrants were adjusted proportionally with corresponding changes to exercise prices.
- Fractional Shares: No fractional shares were issued; holders received cash payments based on the closing price prior to the effective time.
Outlook and Management Commentary
The Company's common stock began trading on a reverse stock split-adjusted basis upon market open on May 20, 2024. The ticker symbol remains "GCTK" on The Nasdaq Stock Market LLC. The filing contains no forward-looking guidance, risk factors, or management commentary regarding future financial performance beyond the mechanics of the stock split.
Investor Verification Checklist
- Verify the adjusted share count and exercise prices for any held stock options or warrants.
- Confirm the receipt of cash payments for any fractional shares that were eliminated.
- Monitor the trading volume and price of GCTK on Nasdaq following the May 20, 2024, adjusted trading start.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for specific legal terms regarding the split.